Clinical Trial Update: Methodology for Developing an Occlusal Appliance With CBD Active Carrier [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update describing methodology for developing an occlusal appliance with a CBD active carrier for temporomandibular disorder and myofascial pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain
• Temporomandibular Disorder

Drugs mentioned

• CBD (cannabidiol)

Snippet

Sponsor: Medical University of Silesia | Conditions: Temporomandibular Disorder, Myofascial Pain | Phase 2, Phase 3 | Status: UNKNOWN